Cancer Prevention Pharmaceuticals Publishes of Landmark Phase 3 Trial
11 Sep 2020 //
BUSINESS WIRE
(CPP) & Mallinckrodt Announce Results from Pivotal Ph3 Trial of CPP-1X/Sulindac
07 May 2019 //
PR NEWSWIRE
11 Sep 2020 //
BUSINESS WIRE
07 May 2019 //
PR NEWSWIRE